Resveratrol increases iodide trapping in the rat thyroid cell line FRTL-5

Thyroid

Volumn 20, Issue 2, 2010, Pages 195-203

  Sebai, Hichem ^a,b   Hovsépian, Sonia ^a   Ristorcelli, Elodie ^a   Aouani, Ezzedine ^b   Lombardo, Dominique ^a   Fayet, Guy ^a  

^a University of the Mediterranean Aix Marseille II   (France)

^b University of Carthage   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR; COTRANSPORTER; CYCLIC AMP; NITRIC OXIDE; RADIOACTIVE IODINE; RESVERATROL; THYROTROPIN;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; EFFUSION; NONHUMAN; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THYROID CANCER; THYROID CARCINOMA; THYROID CELL;

ANIMALS; CELL LINE; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; IODIDES; RATS; STILBENES; SYMPORTERS; THYROID GLAND; THYROTROPIN;

EID: 77149122721     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.0171     Document Type: Article

References (57)

1. Fauconneau B,Waffo-Teguo P,Huget F, Barrier L,DecenditA, Merillon JM 1997 Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci 61:2103-2110.
2. Frankel EN, Waterhouse AL, Kinsella JE 1993 Inhibition of human LDL oxidation by resveratrol. Lancet 341:1103-1104.
3. Maxwell S, Cruickshank A, Thorpe G 1994 Red wine and antioxidant activity in serum. Lancet 344:193-194.
4. Mokni M, Elkahoui S, Limam F, Amri M, Aouani E 2007 Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochem Res 32:981-987.
5. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM 1995 The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 235:207-219.
6. Sbarra V, Ristorcelli E, Le Petit-Thévenin J, Teissedre PL, Lombardo D, Vérine A 2005 In vitro polyphenol effects on activity, expression and secretion of pancreatic bile saltdependent lipase. Biochim Biophys Acta 1736:67-76.
7. Ulrich S, Wolter F, Stein JM 2005 Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis. Mol Nutr Food Res 49:452-461.
8. Wolter F, Ulrich S, Stein J 2004 Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in colorectal cancer: key role of polyamines? J Nutr 134: 3219-3222.
9. Roman V, Billard C, Kern C, Ferry-Dumazet H, Izard JC, Mohammad R, Mossalayi DM, Kolb JP 2002 Analysis of resveratrol-induced apoptosis in human B-cell chronic leukemia. Br J Haematol 117:842-851.
10. Ferry-Dumazet H, Garnier O, Mamani-Matsuda M, Vercauteren J, Belloc F, Billiard C, Dupouy M, Thiolat D, Kolb JP, Marit G, Peiffers J, Mossalay MD 2002 Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. Carcinogenesis 23: 1327-1333.
11. Kuo PL, Chiang LC, Lin CC 2002 Resveratrol-induced apoptosis is mediated by p53-dependent pathway in HepG2 - cells. Life Sci 72:23-34.
12. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y 2004 Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24:2783-2840.
13. Soleas GJ, Diamandis EP, Goldgerg DM 1997 Resveratrol: a molecule whose time has come? and gone? Clin Biochem 30:91-113.
14. Shih A, Davis FB, Lin HY, Davis PJ 2002 Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK-and p53- dependent mechanism. Endocrinol Metab 87:1223-1232.
15. Bottner M, Christoffel J, Rimoldi G, Wuttke W 2006 Effects of long-term treatment with resveratrol and subcutaneous and oral estradiol administration on the pituitary-thyroid axis. Exp Clin Endocrinol Diabetes 114:82-90.
16. Dai G, Levy O, Carrasco N 1996 Cloning and characterization of the thyroid iodide transporter. Nature 379:458-460.
17. Amdur RJ, Mazzaferri EL 2005 Essentials of thyroid cancer management, part 5. In: Medical Therapy of Differentiated Thyroid Cancer. Springer, Heidelberg, pp 163-241.
18. Weiss SJ, Philp NJ, Ambesi-Impiombato FS, Grollman EF 1984 Thyrotropin-stimulated iodide transport mediated by adenosine 30,50 monophosphate and dependent protein synthesis. Endocrinology 114:1099-1107.
19. Bradamante S, Barenghi L, Piccinini F, Bertelli AA, De Jonge R, Beemster P, De Jong JW 2003 Resveratrol provides latephase cardioprotection by means of a nitric oxide and adenosine- mediated mechanism. Eur J Pharmacol 465:115-123.
20. Sala G, Minutola F, Macchia M, Sacchi N, Ghidoni R 2003 Resveratrol structure and ceramide-associated growth inhibition in prostate cancer cells. Drugs Exp Clin Res 29: 263-269.
21. Kiziltepe U, Turan NN, Han U, Ulus AT, Akar F 2004 Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury. J Vasc Surg 40:138-145.
22. Newton RA, Cook AL, Roberts DW, Leonard JH, Sturm RA 2007 Post-transcriptional regulation of melanin biosynthetic enzymes by cAMP and resveratrol in human melanocytes. J Invest Dermatol 127:2216-2227.
23. Mosmann T 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
24. Fayet G, Hovsépian S 1977 Active transport of iodide in isolated porcine thyroid cells. Application to an in vitro bioassay of thyrotropin. Mol Cell Endocrinol 7:67-78.
25. Van Sande J, Massart C, Beauwens R, Schoutens A, Costagliola S, Dumont JE 2003 Anion selectivity by the sodium iodide symporter. Endocrinology 144: 247-252.
26. Hawkes R, Niday E, Gordon J 1982A dot immunobinding assay for monoclonal and other antibodies. Anal Biochem 119:142-147.
27. Fayet G, Aouani A, Hovsépian S 1986 TSH-induced cyclic AMP production in an ovine thyroid cell line:OVNIS 5H. FEBS Lett 194:287-291.
28. Brown RE, Jarvis KL, Hyland KJ 1989 Protein measurement using bicinchoninic acid: elimination of interfering substances. Anal Biochem 180:136-139.
29. Riedel C, Levy O, Carrasco N 2001 Posttranscriptional regulation of the Na/iodide symporter by TSH. J Biol Chem 276:21458-21463.
30. Rapaport B 1978 Acute effects of thyroid-stimilating hormone on cultured thyroid cell morphology. Endocrinology 102:175-181.
31. Harii N, Endo T, Ohmori M, Onaya T 1999 Extracellular adenosine increases Na+/I- symporter gene expression in rat thyroid FRTL-5 cells. Mol Cell Endocrinol 157:31-39.
32. Das S, Cordis GA, Maulik N, Das DK 2005 Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation. Am J Physiol Heart Circ Physiol 288:H328-H335.
33. Provenzano MJ, Fitzgerald MP, Krager K, Domann FE 2007 Increased iodine uptake in thyroid carcinoma after treatment with sodium butyrate and decitabine (5-Aza dC). Otolaryngol Head Neck Surg 137:722-728.
34. Kaindl U, Eyberg I, Rohr-Udilova N, Heinzle C, Marian B 2008 The dietary antioxidants resveratrol and quercetin protect cells from exogenous pro-oxidative damage. Food Chem Toxicol 46:1320-1326.
35. Leer LM, Cammenga M, van der Vorm ER, de Vijder JJ 1991 Methimazole increases thyroid-specific mRNA concentration in human thyroid cells and FRTL-5 cells. Mol Cell Endocrinol 78:221-228.
36. Isozaki O, Tsushima T, Emoto N, Saji M, Tsuchiya Y, Demura H, Sato Y, Shizume K, Kimura S, Kohn LD 1991 Methimazole regulation of thyroglobulin biosynthesis and gene transcription in rat FRTL-5 thyroid cells. Endocrinology 128:3113-3121.
37. Amphoux-Fazekas T, Fayet G, Hovsépian S, Aouani A, Samih N 1997 L'hexaméthylène bisacétamide (HMBA) supprime la perte de sensibilité des cellules thyroïdiennes monocouches de porc à la thyrotropine. CR Acad Sci (Paris) 320:1-11.
38. El Mowafy MA, Alkhalaf M 2003 Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel oestrogen receptor independent cytostatic mechanism. Carcinogenesis 24:869-873.
39. Blumenstein I, Kesern B, Wolter F, Stein J 2005 The chemopreventive agent resveratrol stimulates cAMP-dependent chloride secretion in vitro. Clin Cancer Res 11:5651-5656.
40. Wu CC, Wu CI, Wang WY, Wu YC 2007 Low concentrations of resveratrol potentiate the antiplatelet effect of prostaglandins. Planta Med 73:439-443.
41. Chen YC, Nagpal ML, Stocco DM, Lin T 2007 Effect of genistein, resveratrol and quercetin on steroidogenesis and proliferation of MA-10 mouse Leydig tumor cells. J Endocrinol 192:527-537.
42. ElMowafy AM, Alkhalaf M, Jaffal SM 2007 Non-genomic activation of the GC-A enzyme by resveratrol and estradiol downstream from membrane estrogen receptors in human coronary arterial cells. Nutr Metab Cardiovasc Dis 17:508-516.
43. Donelly LE, Newton R, Kennedy GE, Fenwick PS, Leung RHF, Ito K, Russell REK, Barnes PJ 2004 Anti-inflamatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am J Physiol Lung Cell Mol Physiol 287:L774-L783.
44. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang UU, Scherer B, Sinclair DA 2003 Small molecules activators of sirtuins extend Saccharomyces cerevisae lifespan. Nature 425:191-196.
45. Hung LM, Chen JK, Huang SS, Lee RS, Su MJ 2000 Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc Res 47:549-555.
46. Chander V, Tukey N, Chopra K 2005 Resveratrol, a polyphenolic phytoalexin protects against cyclosporine-induced nephrotoxicity through nitric oxide dependent mechanism. Toxicology 210:55-64.
47. Wang S, Wang X, Yan J, Xie X, Fan F, Zhon X, Han L, Chen J 2007 Resveratrol inhibits proliferation of cultured rat cardiac fibroblasts: correlated with NO-cGMP signaling pathway. Eur J Pharmacol 567:26-35.
48. Tsai SK, Hung LM, Fu YT, Cheng H, Nien MW, Liu HY, Zhang FB, Huang SS 2007 Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats. J Vasc Surg 46:346-353.
49. Mokni M, Limam F, Elkahoui S, Amri M, Aouani E 2007 Strong cardioprotective effect of resveratrol, a red wine polyphenol, on isolated rat hearts after ischemia-reperfusion injury. Arch Biochem Biophys 457:1-6.
50. Bi XL, Yang JY, Dong YX, Wang JM, Cui YH, Ikeshima T, Zhao YQ, Wu CF 2005 Resveratrol inhibits nitric oxide and TNFa production by lipopolysaccharide- activated microglia. Int Immunopharm 5:185-193.
51. Ma ZH, Ma QY, Wang LC, Sha HC, Wu SL, Zhang M 2005 Effect of resveratrol on peritoneal macrophages in rats with severe acute pancreatitis. Inflamm Res 54:522-527.
52. Hung LM, Su MJ, Chen JK 2004 Resveratrol protects myocardial ischemia-reperfusion injury through both NOdependent and NO-independent mechanisms. Free Radic Biol Med 36:774-781.
53. Dimanche-Boitrel MT, Meurette O, rebillard A, Lacour S 2005 Role of early plasma membrane events in chemotherapyinduced cell death. Drug Resist Update 8:5-14.
54. Scarlatti F, Sala G, Somenzi G, Signorelli P, Sacchi N, Ghidoni R 2003 Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling. FASEB J 17:2339-2341.
55. Dolfini E, Roncoroni L, Dogliotti E, Sala G, Erba E, Sacchi N, Ghidoni R 2007 Resveratrol impairs the formation of MDAMB231 multicellular tumor spheroids concomitant with ceramide accumulation. Cancer Lett 249:143-147.
56. Ulrich S, Huwiler A, Loitsch S, Schmidt H, Stein JM 2007 De novo ceramide biosynthesis is associated with resveratrolinduced inhibition of ornithine decarboxylase activity. Biochem Pharmacol 74:281-289.
57. Han YS, Bastianetto S, Dumont Y, Quirion R 2006 Specific plasma membrane binding sites for polyphenols, including resveratrol, in the rat brain. J Pharmacol Exp Ther 318: 238-245.